Top

BMC Cancer

Published in:

Open Access 01-12-2021 | Ultrasound | Research

Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making

Authors: Junping Liu, Xin Liu, Zhengying Guo, Xiaojuan Lv, Weimin Mao, Dong Xu, Lijing Wang

Published in: BMC Cancer | Issue 1/2021

Abstract

Objective

The main aim of this study was to ascertain the effectiveness of ultrasound-guided fine needle aspiration cytology (US-FNAC) in the diagnosis of para-aortic lymph node (PALN) metastasis in uterine cervical cancer and to establish its potential impact on clinical therapeutic decision making.

Methods

We retrospectively reviewed clinical data from 92 patients diagnosed with cervical cancer with PALN enlargement between 2010 and 2018. Cytological results obtained with US-FNAC were classified by the same experienced cellular pathologists. Diagnostic indicators were determined on the basis of biopsy, imaging and clinical follow-up results. Univariate and multivariate analyses were used to assess the differences of influencing factors. The effect of US-FNAC on clinical decision making was evaluated.

Results

Cytological results of US-FNAC were categorized as malignancy (n = 62; 67.4%), suspicious malignancy (n = 11; 12.0%), undetermined (n = 5; 5.4%), benign (n = 10; 10.9%), and inadequate (n = 4; 4.3%). Satisfactory biopsy samples were obtained from 95.7% of PALNs sampled (88/92). The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of FNAC in distinguishing benign from malignant cases were 90.1% (95% CI: 0.809–0.953), 100% (95% CI: 0.561–1), 100% (95% CI: 0.938–1), 46.7% (95% CI: 0.223–0.726) and 90.9% (95% CI: 0.848–0.970), respectively. Univariate analysis indicated significant differences in experience of puncture physicians (radiologists) between the correct and wrong diagnosis groups (P < 0.05), which was further confirmed as an independent predictor of diagnostic accuracy in multivariate analysis (p = 0.031, OR = 0.077, 95% CI: 0.354–0.919). All patients tolerated the US-FNAC procedure well and only nine presented slight abdominal discomfort. The therapeutic strategies for 74 patients (80.4%) were influenced by US-FNAC findings.

Conclusions

US-FNAC was a relatively safe and effective technique for examination of enlarged para-aortic lymph nodes and may therefore serve as a routine diagnostic tool to guide clinical decision making for management of cervical cancer.

Available only for authorised users

Shim SH, Kim DY, Lee SJ, Kim SN, Kang SB, Lee SW, et al. Prediction model for Para-aortic lymph node metastasis in patients with locally advanced cervical cancer. Gynecol Oncol. 2017;144(1):40–5. https://doi.org/10.1016/j.ygyno.2016.11.011.CrossRefPubMed

Hwang L, Bailey A, Lea J, Albuquerque K. Para-aortic nodal metastases in cervical cancer: a blind spot in the International Federation of Gynecology and Obstetrics staging system: current diagnosis and management. Future Oncol. 2015;11(2):309–22. https://doi.org/10.2217/fon.14.200.CrossRefPubMed

Eisenhauer EA, Terasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47. https://doi.org/10.1016/j.ejca.2008.10.026.CrossRefPubMed

Yang WT, Lam WM, Yu MY, et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol. 2000;175(3):759–66. https://doi.org/10.2214/ajr.175.3.1750759.CrossRefPubMed

Liu B, Gao S, Li S. A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical Cancer: a meta-analysis based on 67 studies. Gynecol Obstet Investig. 2017;82(3):209–22. https://doi.org/10.1159/000456006.CrossRef

Atri M, Zhang Z, Dehdashti F, Lee SI, Ali S, Marques H, et al. Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: results of ACRIN6671/GOG0233 trial. Gynecol Oncol. 2016;142(3):413–9. https://doi.org/10.1016/j.ygyno.2016.05.002.CrossRefPubMedPubMedCentral

Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee SI. Identifcation of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET/CT: analysis from the ACRIN 6671/GOG 0233 multicenter trial. Radiology. 2018;287(1):176–84. https://doi.org/10.1148/radiol.2017170963.CrossRefPubMed

Brunette LL, Bonyadlou S, Ji L, Groshen S, Shuster D, Mehta A, et al. Predictive value of FDG PET/CT to detect lymph node metastases in cervical Cancer. Clin Nucl Med. 2018;43(11):793–801. https://doi.org/10.1097/RLU.0000000000002252.CrossRefPubMedPubMedCentral

Achouri A, Huchon C, Bats AS, Bensaid C, Nos C, Lécuru F. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol. 2013;39(1):81–6. https://doi.org/10.1016/j.ejso.2012.10.011.CrossRefPubMed

10.

De Filippo M, Saba L, Rossi E, et al. Curved needles in CT-guided fine needle biopsies of abdominal and retroperitoneal small lesions. J Vasc Interv Radiol. 2015;38(6):1611–6.

11.

Shao H, McCarthy C, et al. CT-guided percutaneous needle biopsy of retroperitoneal and pelvic lymphadenopathy: assessment of technique, diagnostic yield, and clinical value. J Vasc Interv Radiol. 2018;29(10):1429–36.CrossRef

12.

Meme OS, Dodd GD III, Esola CC. Efficacy of sonography as a guidance technique for biopsy of abdominal, pelvic and retroperitoneal lymph nodes. AJR. 1996;167(4):957–62. https://doi.org/10.2214/ajr.167.4.8819394.CrossRef

13.

Fisher AJ, Paulson EK, Sheafor DS, et al. Small lymph nodes of the abdomen, pelvis, and retroperitoneum: usefulness of sonographically guided biopsy. Radiology. 1997;205(1):185–90. https://doi.org/10.1148/radiology.205.1.9314983.CrossRefPubMed

14.

Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Radiology. 1991;178(1):253–8. https://doi.org/10.1148/radiology.178.1.1984314.CrossRefPubMed

15.

National Comprehensive Cancer Network. Cervical cancer clinical practice guidelines in oncology (2020). https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.

16.

Screaton NJ, Berman LH, Grant JW. Head and neck lymphadenopathy: evaluation with US-guided cutting-needle biopsy. Radiology. 2002;224(1):75–81. https://doi.org/10.1148/radiol.2241010602.CrossRefPubMed

17.

Kurita A, Kodama Y, Nakamoto Y, Isoda H, Minamiguchi S, Yoshimura K, et al. Impact of EUS-FNA for preoperative Para-aortic lymph node staging in patients with pancreatobiliary cancer. Gastrointest Endosc. 2016;84(3):467–75. https://doi.org/10.1016/j.gie.2016.02.045.CrossRefPubMed

18.

Stattaus J, Kalkmann J, Kuehl H, Metz KA, Nowrousian MR, Forsting M, et al. Diagnostic yield of computed tomography-guided coaxial core biopsy of undetermined masses in the free retroperitoneal space: single-center experience. Cardiovasc Intervent Radiol. 2008;31(5):919–25. https://doi.org/10.1007/s00270-008-9317-5.CrossRefPubMed

19.

Avritscher R, Krishnamurthy S, Ensor J, Gupta S, Tam A, Madoff DC, et al. Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer. 2010;116(8):1974–80. https://doi.org/10.1002/cncr.24968.CrossRefPubMed

Title: Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making
Authors: Junping Liu
Xin Liu
Zhengying Guo
Xiaojuan Lv
Weimin Mao
Dong Xu
Lijing Wang
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Ultrasound
Metastasis
Foreign Body Aspiration
Cervical Cancer
Foreign Body Aspiration
Aspiration
Cervical Cancer
Ultrasound
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08492-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types

Breast-cancer detection using blood-based infrared molecular fingerprints

Knock-down of LRP/LR influences signalling pathways in late-stage colorectal carcinoma cells

The effect of hypoxia on PD-L1 expression in bladder cancer

Results of the observational prospective RealFLOT study

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer